相关产品推荐更多 >
![5,6,7,8-四氢-[1,2,4]三唑并[4,3-a]吡嗪二.盐.酸盐,5,6,7,8-Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine dihydrochloride,97%,1429056-45-0](https://img1.dxycdn.com/2021/1202/025/1438838799382748153-14.jpg!wh200)
5,6,7,8-四氢-[1,2,4]三唑并[4,3-a]吡嗪二.盐.酸盐,5,6,7,8-Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine dihydrochloride,97%,1429056-45-0
¥100![7,7-二甲基-2,3,4,6,7,8-六氢-1H-环戊基[4,5]吡.咯[1,2-a]吡嗪-1-酮,7,7-Dimethyl-2,3,4,6,7,8-hexahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one,95%,1346674-23-4](https://img1.dxycdn.com/2021/1129/847/6813930756281397153-14.jpg!wh200)
7,7-二甲基-2,3,4,6,7,8-六氢-1H-环戊基[4,5]吡.咯[1,2-a]吡嗪-1-酮,7,7-Dimethyl-2,3,4,6,7,8-hexahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one,95%,1346674-23-4
¥100
1-(5-Isoquinolinesulfonyl)-2-methyl-4-trityl-piperazine,
¥100
间甲基苯甲.醚,1-Methoxy-3-methyl.benzene,99+%,100-84-5
¥100![N-(三氟甲.基磺.酸基)-1,8-萘二甲酰亚胺,1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate,97%,85342-62-7](https://img1.dxycdn.com/2021/1129/466/3156769501291397153-14.jpg!wh200)
N-(三氟甲.基磺.酸基)-1,8-萘二甲酰亚胺,1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate,97%,85342-62-7
¥100
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
咨询
- 保质期:
咨询
- 英文名:
4,4'-(Diazene-1,2-diyl)dibenzoic acid
- 库存:
咨询
- 供应商:
无锡云萃生物
- CAS号:
586-91-4
- 规格:
5mg/50mg/100mg/500mg
| 规格: | 5mg | 产品价格: | ¥100.0 |
|---|---|---|---|
| 规格: | 50mg | 产品价格: | ¥100.0 |
| 规格: | 100mg | 产品价格: | ¥100.0 |
| 规格: | 500mg | 产品价格: | ¥100.0 |
云萃
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验?isobutyryl?5??O ?(4,4??dimethoxytrityl)?2??O ?(propargyl)guanosine is converted to its 3??O ?levulinyl ester in a yield of 91%. The reaction of commercial N 2 ?isobutyryl?5??O ?(4,4??dimethoxytrityl)?2??O ?tert ?butyldimethylsilyl?3??O ?[(2?cyanoethyl)?N ,N
2 x2H2 O 1M 147.02g/M 13.54 7.351g 29.40g 44.11g H2 O mQ 86.46 46.92ml 187.7ml 281.5ml Conc. Stock %(w/w) 50ml 200ml 300ml CaCl2 x 6H2 O 1M 219.08g/M 20.18 10.95g 43.82
the pH or the chromatographic material used for peptide purification (27, 110, 116). (i) Phosphopeptide sequencing by MS/MS. In our laboratory, we have found that a combination of HPLC, Edman degradation, and phosphopeptide sequencing
技术资料暂无技术资料 索取技术资料




